Liver Fibrosis Market to Reach US$ 4,897.7 Million by 2033, at CAGR of 7.7% from 2023 to 2033, IMARC Group

The newly published report by IMARC Group, titled "Liver Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the liver fibrosis market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.

How big is the market for liver fibrosis?

According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for liver fibrosis market amounted to US$ 2,152.0 Million. Looking forward, these markets are anticipated to reach US$ 4,897.7 Million by 2033, at a growth rate (CAGR) of 7.7% from 2023-2033.

Request for a Sample Report: https://www.imarcgroup.com/liver-fibrosis-market/requestsample

What is liver fibrosis?

Liver fibrosis is the result of the abnormal formation of fibrous tissue or scarring in the liver due to injury or damage. With time, the accumulation of scar cells can cause the liver to become rigid and lose its normal functionality. Individuals affected by this condition may experience reduced appetite, cognitive difficulties, fluid retention in the legs or abdomen, breathlessness, nausea, unexplained weight loss, muscle weakness, etc. The diagnosis of liver fibrosis includes a complete evaluation of the patient's medical history, a liver biopsy, and various diagnostic procedures, such as ultrasonography, computed tomography, magnetic resonance imaging, etc.

Explore the Full Report with Table of Contents: https://www.imarcgroup.com/liver-fibrosis-market

What are the key drivers and trends in the liver fibrosis market?

The growing cases of injury and inflammation in the liver, which lead to an excessive buildup of proteins between the hepatic cells, are primarily driving the liver fibrosis market. Besides this, the increasing instances of various associated risk factors, such as daily alcohol consumption, obesity, destruction of the bile ducts, autoimmune hepatitis, etc., are also augmenting the market growth. Moreover, the rising utilization of antifibrotic drugs, including belapectin, cenicriviroc, liraglutide, etc., that help minimize the likelihood of permanent liver scarring in patients is acting as another significant growth-inducing factor.

Additionally, the inflating demand for next-generation plasma protein profiling, as it aids in understanding the disease mechanisms that can guide personalized treatment strategies, is positively influencing the market growth. Furthermore, the increasing popularity of cell therapy for the curing of this illness, owing to its ability to repair or replace damaged cells in the liver and promote the production of hepatic enzymes, is expected to propel the liver fibrosis market in the coming years.

What is included in the report segmentation?

The report covers the following aspects:

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the liver fibrosis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the liver fibrosis market
Reimbursement scenario in the market
In-market and pipeline drugs

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/request?type=report&id=7697&flag=C

How This Report Can Help You:

The report on liver fibrosis market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the liver fibrosis market.

The liver fibrosis market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.

Our report on the liver fibrosis market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.

Browse Our Latest Healthcare Research Report:
Major Depressive Disorder Market Report 2023-2033: https://www.imarcgroup.com/major-depressive-disorder-market

Malignant Pleural Mesothelioma Market Report 2023-2033: https://www.imarcgroup.com/malignant-pleural-mesothelioma-market

Myelodysplastic Syndrome Market Report 2023-2033: https://www.imarcgroup.com/myelodysplastic-syndrome-market

Opioid-Induced Constipation Market Report 2023-2033: https://www.imarcgroup.com/opioid-induced-constipation-market

Key Questions Answered in this Report:

How has the liver fibrosis market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the liver fibrosis market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the liver fibrosis market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

About Us: -

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

This release was published on openPR.